glp-1 receptor agonists show promise in treating substance use disorders Regulation of GLP-1 and Glucagon
Description
Chetty, and Jalpa Doshi
The least square mean (LSM) change in HbA1c from baseline at week 52 was 2.4%, 2.6% and 2.8% with tirzepatide 5 mg, 10 mg, and 15 mg, respectively, versus 1.3% with dulaglutide
These record sales have occurred despite limited insurance coverage in the U.S., with neither Wegovy nor Zepbound broadly covered by employer plans or Medicare
In the end of the tale, Simpleton is unexpectedly wins the hand of a local princess and they all live happily ever after
